ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹1309 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 0.51% | -0.44% |
6 Month | 9.91% | 12.19% |
1 Year | -3.67% | -1.57% |
3 Year | 22.03% | 24.28% |
5 Year | - | 18.06% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 1.94% | 3.9% |
1 Year | 3.79% | 9.27% |
3 Year | 19.77% | 22.51% |
5 Year | - | 19.09% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 19.5% | 10.55% |
3 Year | 19.53% | 18.34% |
5 Year | - | 15.18% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.57% | 15.94% |
Sharp | 0.86% | 0.99% |
Beta | 0.95% | 0.98% |
Alpha | -2.07% | -0.12% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.23 | 4.61 |
Large Cap | 29.73 | 28.41 |
Mid Cap | 37.1 | 35.03 |
Small Cap | 28.95 | 31.95 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.13 | 2.56 |
Healthcare | 90.65 | 94.45 |
Basic Materials | 3.99 | 1.44 |
Industrials | 1.99 | - |
Financial Services | 1.24 | 1.56 |
Top Comparisons
Nippon India Growth Mid Cap Fund-Growth Plan-Growth Option
3Y Returns24.42%
UTI Mid Cap Fund-Growth Option
3Y Returns16.59%
Sundaram ELSS Tax Saver Fund Regular Growth
3Y Returns15.1%
Sundaram Tax Savings Fund (Formerly Known as Principal Tax Savings Fund) Regular Growth
3Y Returns15.1%
FRANKLIN INDIA MONEY MARKET FUND-GROWTH
3Y Returns7.42%
Kotak Money Market Fund - (Growth)
3Y Returns7.46%
Aditya Birla Sun Life Asset Allocator FoF- Regular Plan - Growth Option
3Y Returns16.53%
Kotak Multi Asset Omni FOF - Growth
3Y Returns19.47%